awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36954038-ADD9DCB3-3D25-4DCA-BCDB-96436F6E69B4
Q36954038-ADD9DCB3-3D25-4DCA-BCDB-96436F6E69B4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36954038-ADD9DCB3-3D25-4DCA-BCDB-96436F6E69B4
Lamivudine-resistant rtL180M and rtM204I/V are persistently dominant during combination rescue therapy with entecavir and adefovir for hepatitis B.
P2860
Q36954038-ADD9DCB3-3D25-4DCA-BCDB-96436F6E69B4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36954038-ADD9DCB3-3D25-4DCA-BCDB-96436F6E69B4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f91b51b4d6cd66550e45ff1a53f467ae557fde35
P2860
Rescue therapy for lamivudine-resistant chronic hepatitis B: comparison between entecavir 1.0 mg monotherapy, adefovir monotherapy and adefovir add-on lamivudine combination therapy.